Idexx Laboratories Inc

Research Idexx Laboratories Inc (IDXX) on Bullrun: valuation model: fairly valued, market cap USD 42.28B, P/E 39.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIDXX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Valuation signalfairly valued
• Market capUSD 42.28B
• P/E39.4
• Financial periodFY2025
• RevenueUSD 4.30B
• Revenue growth10.4%
• Net incomeUSD 1.06B
• Free cash flowUSD 1.06B
• Gross margin61.8%

Valuation Snapshot

Bullrun's latest valuation model marks Idexx Laboratories Inc as fairly valued; latest market cap is USD 42.28B; P/E is 39.4.

About Idexx Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers;

Frequently asked questions

Is Idexx Laboratories Inc overvalued or undervalued?

Bullrun's valuation model currently marks Idexx Laboratories Inc as fairly valued.

What is Idexx Laboratories Inc's market cap?

Idexx Laboratories Inc's market capitalization is USD 42.28B.

What is Idexx Laboratories Inc's P/E ratio?

Idexx Laboratories Inc's price-to-earnings (P/E) ratio is 39.4.

What does Idexx Laboratories Inc do?

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products;